82 related articles for article (PubMed ID: 10436859)
1. Mutations in the human 5-lipoxygenase gene.
In KH; Silverman ES; Asano K; Beier D; Fischer AR; Keith TP; Serino K; Yandava C; De Sanctis GT; Drazen JM
Clin Rev Allergy Immunol; 1999; 17(1-2):59-69. PubMed ID: 10436859
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
In KH; Asano K; Beier D; Grobholz J; Finn PW; Silverman EK; Silverman ES; Collins T; Fischer AR; Keith TP; Serino K; Kim SW; De Sanctis GT; Yandava C; Pillari A; Rubin P; Kemp J; Israel E; Busse W; Ledford D; Murray JJ; Segal A; Tinkleman D; Drazen JM
J Clin Invest; 1997 Mar; 99(5):1130-7. PubMed ID: 9062372
[TBL] [Abstract][Full Text] [Related]
3. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants.
Silverman ES; Du J; De Sanctis GT; Rådmark O; Samuelsson B; Drazen JM; Collins T
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):316-23. PubMed ID: 9698605
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of 5-lipoxygenase transcription.
Drazen JM; Silverman ES
Int Arch Allergy Immunol; 1999; 118(2-4):275-8. PubMed ID: 10224409
[TBL] [Abstract][Full Text] [Related]
5. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population.
Sayers I; Barton S; Rorke S; Sawyer J; Peng Q; Beghé B; Ye S; Keith T; Clough JB; Holloway JW; Sampson AP; Holgate ST
Clin Exp Allergy; 2003 Aug; 33(8):1103-10. PubMed ID: 12911785
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of the 5-lipoxygenase pathway in asthma.
Silverman E; In KH; Yandava C; Drazen JM
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():164-70; discussion 171-3. PubMed ID: 9988463
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B
FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA methylation and methyl-DNA binding proteins in the repression of 5-lipoxygenase promoter activity.
Katryniok C; Schnur N; Gillis A; von Knethen A; Sorg BL; Looijenga L; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2010 Jan; 1801(1):49-57. PubMed ID: 19781662
[TBL] [Abstract][Full Text] [Related]
10. Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity.
Dabrowska M; Sirotnak FM
Gene; 2004 Oct; 341():129-39. PubMed ID: 15474296
[TBL] [Abstract][Full Text] [Related]
11. HNE-induced 5-LO expression is regulated by NF-{kappa}B/ERK and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages.
Lee SJ; Kim CE; Seo KW; Kim CD
Cardiovasc Res; 2010 Nov; 88(2):352-9. PubMed ID: 20554538
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterizations of the 5'-flanking region of the mouse glucagon receptor gene: comparison with the rat gene.
Geiger A; Decaux JF; Burcelin R; Le Cam A; Salazar G; Charron MJ; Girard J; Kervran A
Biochem Biophys Res Commun; 2000 Jun; 272(3):912-21. PubMed ID: 10860851
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional analysis of the mouse 5-lipoxygenase promoter.
Silverman ES; Le L; Baron RM; Hallock A; Hjoberg J; Shikanai T; Storm van's Gravesande K; Auron PE; Lu W
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):475-83. PubMed ID: 11919084
[TBL] [Abstract][Full Text] [Related]
14. Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: a case-control study.
Maznyczka A; Braund P; Mangino M; Samani NJ
Atherosclerosis; 2008 Aug; 199(2):328-32. PubMed ID: 18179798
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
16. GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site.
Dishart D; Schnur N; Klan N; Werz O; Steinhilber D; Samuelsson B; Rådmark O
Biochim Biophys Acta; 2005 Dec; 1738(1-3):37-47. PubMed ID: 16413224
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness.
Kim SH; Bae JS; Suh CH; Nahm DH; Holloway JW; Park HS
Allergy; 2005 Jun; 60(6):760-5. PubMed ID: 15876305
[TBL] [Abstract][Full Text] [Related]
18. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
Le Mée S; Fromigué O; Marie PJ
Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
Drazen JM; Yandava CN; Dubé L; Szczerback N; Hippensteel R; Pillari A; Israel E; Schork N; Silverman ES; Katz DA; Drajesk J
Nat Genet; 1999 Jun; 22(2):168-70. PubMed ID: 10369259
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site.
Sorg BL; Klan N; Seuter S; Dishart D; Rådmark O; Habenicht A; Carlberg C; Werz O; Steinhilber D
Biochim Biophys Acta; 2006 Jul; 1761(7):686-97. PubMed ID: 16750418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
